NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 29, 2025 — Glucotrack Inc. is set to host a virtual webinar discussing its groundbreaking Continuous Blood Glucose Monitor (CBGM) technology, offering insights into the future of diabetes management. Learn how this innovation could reshape traditional glucose monitoring methods and improve the lives of millions affected by diabetes.
May 28, 2025 — TransCode Therapeutics appoints Dr. Phillip D. Zamore, a leading figure in RNA research, to its Scientific Advisory Board. The addition enhances the company's focus on RNA-targeted cancer therapy programs, marking a strategic development in the fight against metastatic disease.
May 28, 2025 — Bioadaptives showcases remarkable clinical results for Regen(TM) Dog Chews, offering a safe and effective solution for improving canine health and vitality. With a 281.3% increase in circulating stem cells and a proprietary rating system, this premium pet wellness product stands out for its natural ingredients and proven benefits.
May 28, 2025 — TransCode Therapeutics appoints Dr. Phillip D. Zamore, a leading figure in RNA research, to its Scientific Advisory Board, enhancing its cancer therapy programs. The addition of Dr. Zamore underscores the company's commitment to developing innovative RNA therapeutics for metastatic disease.
May 28, 2025 — The U.S. House of Representatives approval of the reconciliation bill for the 2025 budget with a one-vote difference will have significant impacts on healthcare insurance and Medicaid. Learn more about the potential changes and implications of this legislation.
May 28, 2025 — Renowned RNA expert Dr. Phillip D. Zamore joins TransCode Therapeutics' Scientific Advisory Board, enhancing the company's cancer therapy programs. This strategic addition highlights the potential of RNA therapeutics for treating metastatic tumors and revolutionizing oncology.
May 28, 2025 — Quantum BioPharma (NASDAQ: QNTM) receives approval for Phase 2 clinical trial of FSD202, a potential treatment for chronic pain associated with MCAS. The trial aims to measure pain reduction over 56 days, offering hope for patients with this debilitating disorder.
May 28, 2025 — NanoViricides, Inc. (NNVC) to present at BIO International Convention 2025 in Boston, discussing antiviral drug pipeline including NV-387. Learn more about the company's innovative approach to viral treatment.
May 28, 2025 — Oragenics announces a 1-for-30 reverse stock split to boost share price and appeal to investors. CEO Janet Huffman aims to enhance the company's capital markets profile while advancing treatments for brain-related health conditions.
May 28, 2025 — Healthcare Triangle, Inc. (HCTI) announces new strategic contracts and AI advancements in the healthcare sector, positioning the company as a key player in digital transformation solutions for improved patient care.
May 28, 2025 — New research reveals racial and ethnic disparities in sodium intake, emphasizing the need for customized advice. Understanding cultural differences in salt usage is crucial for reducing high blood pressure and cardiovascular disease risk.
May 28, 2025 — Unchained Leader program receives global recognition for positive impact on mental health. Founded by Mason Cain, the 90-day self-help program offers personalized treatment plans and a supportive community for lasting healing and freedom.
May 27, 2025 — GeoVax Labs announces strong support for FDA's updated COVID-19 vaccine recommendations, highlighting the importance of tailored vaccine solutions for vulnerable populations. Learn how the multi-antigen vaccine, GEO-CM04S1, aims to provide comprehensive immune responses in high-risk individuals.
May 27, 2025 — Discover how a new swallowable pill is changing the game for gut health monitoring. Learn how advancements in tracking mucosal barrier integrity could revolutionize the diagnosis and treatment of gut-related conditions. Stay informed on the latest breakthroughs in healthcare technology.
May 27, 2025 — Discover the gold standard in aesthetic surgery at The Maercks Institute, where innovation and elegance meet for pain-free procedures and natural results. Dr. Rian Maercks' global perspective on beauty sets a new standard in patient care, providing a uniquely refined path to self-enhancement.
May 27, 2025 — Nutriband CEO Gareth Sheridan discusses the company's AVERSA(TM) platform in The BioMedWire Podcast, offering insights into transdermal drug delivery systems and pain management. Learn how Nutriband aims to improve safety and accessibility in the fentanyl patch market.
May 27, 2025 — Healthcare Triangle, Inc. (HCTI) unveils QuantumNexis, a subsidiary focused on AI-powered SaaS solutions for healthcare. With the acquisition of Niyama Healthcare and Ezovion Solutions, HCTI aims to address global healthcare demands and lead in Gen AI-powered technology.
May 27, 2025 — American Heart Association launches initiative to improve access to gene editing therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) in underserved populations. Learn how this program aims to enhance patient care and outcomes for a specific heart condition.
May 25, 2025 — Skin, Bones, Hearts & Private Parts is hosting a CME conference in Nashville, TN from August 25-28, 2025. Earn up to 26 CME credits and 7.50 APRN Pharmacology credits. Expert speakers to cover Dermatology, Diabetes, Orthopedics, Women's Health, Cardiology, and Emergency Medicine.
May 24, 2025 — CD BioSciences launches customizable aging mouse models for drug development, providing valuable tools for researchers in the aging research sector. With precision-driven customization and accelerated drug development timelines, CD BioSciences offers a strategic edge for pharmaceutical companies in aging-related drug discovery.